Login
Search result (1-20 of 82)Download
|
Symbol
|
KYUADU | RMBQ5V | KZEHDU | KZFDDU | KZJVDU | RMBAIV | Z0ARGZ | ACGJTQ | MBSTJB | MBUMJB | MBSPJB | PUIRCH | KZXVDU | ACMVSQ | ADAATQ | LAGLDU | LALBDU | RMAY9V | ADXETQ | LAUJDU |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Lock-In Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible |
|
Underlying
|
Eli Lilly / Merck & Co. / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Bristol Myers / Eli Lilly / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | AstraZeneca Plc / Eli Lilly & Co. / Merck & Co. Inc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly / Johnson & Johnson / Pfizer | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
18.09.2026 | 17.11.2026 | 20.11.2026 | 30.11.2026 | 30.12.2026 | 30.12.2026 | 03.09.2026 | 03.09.2026 | 15.09.2026 | 15.09.2026 | 15.09.2026 | 17.09.2026 | 08.09.2026 | 23.11.2026 | 27.11.2026 | 07.12.2026 | 02.07.2027 | 14.01.2027 | 12.02.2027 | 01.03.2027 |
| Bid | - | 40.800 | - | - | - | 53.10 | 109.78 | 49.040 | - | - | - | 51.84 | - | 73.26 | 72.71 | - | - | 70.00 | 100.91 | - |
| Ask | - | - | - | - | - | - | 110.53 | - | - | - | - | - | - | - | - | - | - | - | 101.72 | - |
Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.
Your Bookmarks (0)